MoonLake Immunotherapeutics (MLTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for MoonLake Immunotherapeutics, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.74x | -28.62x | -82.39x | -6.17x | -6.81x | -1853.11x |
| P/B Ratio | 2.79x | 7.62x | 5.98x | 6.30x | -31.36x | 1.50x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 9.27x | 21.11x | 51.59x | 9.98x | 0.46x | 12.93x |
| Quick Ratio | 9.27x | 21.11x | 51.59x | 9.98x | 0.46x | 12.93x |
| Leverage | ||||||
| Debt/Equity | 0.25x | 0.01x | 0.01x | 0.01x | -1.29x | 0.00x |
YoY = year-over-year change. Source: FMP..